Shanghai Junshi Biosciences Co., Ltd. is a prominent biopharmaceutical company based in China, engaged in the research, development, and commercialization of innovative therapeutics for a range of dis... Shanghai Junshi Biosciences Co., Ltd. is a prominent biopharmaceutical company based in China, engaged in the research, development, and commercialization of innovative therapeutics for a range of diseases. The company's primary focus lies in the discovery and production of novel antibodies and biologics aimed at treating cancer, autoimmune, metabolic, and infectious diseases. As a key player in China's rapidly advancing biotech industry, Shanghai Junshi Biosciences is known for leveraging cutting-edge technologies such as monoclonal antibodies and bispecific antibodies in its product development pipeline. Through strategic collaborations and partnerships with global pharmaceutical firms, the company enhances its R&D capabilities and extends its reach beyond domestic borders. With a commitment to addressing unmet medical needs, Shanghai Junshi Biosciences plays a vital role in the healthcare and life sciences sectors, offering potential groundbreaking treatments and contributing significantly to the global biotech landscape.
Pending data availability
EU Taxonomy Data missing for Shanghai Junshi Biosciences
We haven’t collected EU Taxonomy data for Shanghai Junshi Biosciences yet, or the company
hasn’t made it publicly available.